Related references
Note: Only part of the references are listed.Syndecans - key regulators of cell signaling and biological functions
Nikolaos A. Afratis et al.
FEBS JOURNAL (2017)
Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
Ingrid Benedicte Moss Kolseth et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line
Hao Jin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Sherif Abdelaziz Ibrahim et al.
MOLECULAR CANCER (2017)
The sweet spot: how GAGs help chemokines guide migrating cells
Yoan Monneau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth
DeannaLee M. Beauvais et al.
CANCER RESEARCH (2016)
Chemokines and their receptors: insights from molecular modeling and crystallography
Irina Kufareva
CURRENT OPINION IN PHARMACOLOGY (2016)
MicroRNAs: exploring new horizons in osteoarthritis
M. Nugent
OSTEOARTHRITIS AND CARTILAGE (2016)
microRNA-140 Inhibits Inflammation and Stimulates Chondrogenesis in a Model of Interleukin 1β-induced Osteoarthritis
Tommy A. Karlsen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions
Kirti V. Sawant et al.
SCIENTIFIC REPORTS (2016)
Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation
Vemana Gowd et al.
WORLD JOURNAL OF DIABETES (2016)
Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis
Hao-tang Wei et al.
BMC GASTROENTEROLOGY (2015)
High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression
Qing Qing et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells
Hooi Ching Lim et al.
MOLECULAR CANCER (2015)
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy
Karen M. Doody et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation
Tobias Polte et al.
NATURE COMMUNICATIONS (2015)
Shed syndecan-2 inhibits angiogenesis
Giulia De Rossi et al.
JOURNAL OF CELL SCIENCE (2014)
Structural Basis of Receptor Sulfotyrosine Recognition by a CC Chemokine: The N-Terminal Region of CCR3 Bound to CCL11/Eotaxin-1
Christopher J. Millard et al.
STRUCTURE (2014)
Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice
Oksana Kehoe et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Syndecans as modulators and potential pharmacological targets in cancer progression
Despoina Barbouri et al.
FRONTIERS IN ONCOLOGY (2014)
Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus
Jing-Bo Wang et al.
ACTA DIABETOLOGICA (2013)
Syndecan-1 Overexpression Is Associated With Nonluminal Subtypes and Poor Prognosis in Advanced Breast Cancer
Thuy L. Nguyen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Adult Cartilage-Specific Peroxisonrie Proliferator-Activated Receptor Gamma Knockout Mice Exhibit the Spontaneous Osteoarthritis Phenotype
Faezeh Vasheghani et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice
Jessica Bertrand et al.
ARTHRITIS AND RHEUMATISM (2013)
1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment
Chong-Fai Mok et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies
Vishnu C. Ramani et al.
FEBS JOURNAL (2013)
Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1Rv3 integrin complex in tumorigenesis and angiogenesis
Alan C. Rapraeger
FEBS JOURNAL (2013)
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Hebatallah Hassan et al.
FEBS JOURNAL (2013)
Syndecan-2 is a key regulator of transforming growth factor beta 2/smad2-mediated adhesion in fibrosarcoma cells
Maria Mytilinaiou et al.
IUBMB LIFE (2013)
Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells
Keiji Shimada et al.
JOURNAL OF PATHOLOGY (2013)
Interstitial Dendritic Cell Guidance by Haptotactic Chemokine Gradients
Michele Weber et al.
SCIENCE (2013)
Enhanced syndecan-1 expression on neutrophils in patients with type 2 diabetes mellitus
Jing-Bo Wang et al.
ACTA DIABETOLOGICA (2012)
Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis
Adelheid Korb-Pap et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
P. G. Dedes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The role of synovitis in osteoarthritis pathogenesis
Carla R. Scanzello et al.
BONE (2012)
Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism
Sherif A. Ibrahim et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment
Pavani Gangavarapu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes
Maria Francesca Baietti et al.
NATURE CELL BIOLOGY (2012)
Molecular functions of syndecan-1 in disease
Yvonne Hui-Fang Teng et al.
MATRIX BIOLOGY (2012)
Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion
Anneleen Pletinck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
Maria E. Lendorf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Targeted Silencing of Heparanase Gene by Small Interfering RNA Inhibits Invasiveness and Metastasis of Osteosarcoma Cells
Lei Fan et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2011)
Attenuation of Tumor Growth by Formation of Antiproliferative Glycosaminoglycans Correlates with Low Acetylation of Histone H3
Ulrika Nilsson et al.
CANCER RESEARCH (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation
DeannaLee M. Beauvais et al.
JOURNAL OF CELL SCIENCE (2010)
Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer
Keiji Shimada et al.
CANCER SCIENCE (2009)
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion
Juan Carlos Rodriguez-Manzaneque et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis
Frank Echtermeyer et al.
NATURE MEDICINE (2009)
Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients
Takuji Iwamoto et al.
FEBS JOURNAL (2008)
The role of syndecans in the regulation of body weight and synaptic plasticity
Ofer Reizes et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5
Kazutaka Hayashida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function
Lars Bode et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma
Yong-Quan Chu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1
Lot de Witte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karene Mahtouk et al.
BLOOD (2007)
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype
Fusun Baba et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: A proposed mechanism for stabilization of extracellular lipoprotein lipase
Ofer Reizes et al.
BIOCHEMISTRY (2006)
ADAMTS5-mediated aggrecanolysis in murine epiphyseal chondrocyte cultures
M. C. Stewart et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
Syndecan-1 expression by stromal. broblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis
T Maeda et al.
ONCOGENE (2006)
The role of heparan sulphate in inflammation
Christopher R. Parish
NATURE REVIEWS IMMUNOLOGY (2006)
Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4
S Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium
AM Patterson et al.
ARTHRITIS AND RHEUMATISM (2005)
Basement membrane proteoglycans: From cellar to ceiling
RV Iozzo
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Chemokines and Their Receptors in Rheumatoid Arthritis Future Targets?
Alisa E. Koch
ARTHRITIS AND RHEUMATISM (2005)
ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1
G Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Indian hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis
T Shimo et al.
DEVELOPMENTAL DYNAMICS (2004)
Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells
T Maeda et al.
CANCER RESEARCH (2004)
Mammary gland development requires syndecan-1 to create a β-catenin/TCF-responsive mammary epithelial subpopulation
BY Liu et al.
ONCOGENE (2003)
Syndecan 3 intramembrane proteolysis is presenilin/γ-secretase-dependent and modulates cytosolic signaling
JG Schulz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Impaired fracture healing in the absence of TNF-α signaling:: The role of TNF-α in endochondral cartilage resorption
LC Gerstenfeld et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement
B Roscic-Mrkic et al.
BLOOD (2003)
Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells
DM Beauvais et al.
EXPERIMENTAL CELL RESEARCH (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
The physiological function of the agouti-related peptide gene: the control of weight and metabolic rate
TM Mizuno et al.
ANNALS OF MEDICINE (2003)
Syndecan captures, protects, and transmits HIV to T lymphocytes
MD Bobardt et al.
IMMUNITY (2003)
Syndecan-3 is a selective regulator of chondrocyte proliferation
T Kirsch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: Tubulin-dependent rearrangements
U Brockstedt et al.
EXPERIMENTAL CELL RESEARCH (2002)
cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor
B Lee et al.
JOURNAL OF VIROLOGY (2001)
Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes
D Pfander et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas
S Mikami et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1α requires interaction with cell surface heparan sulfate proteoglycans
A Valenzuela-Fernández et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery
A Anttonen et al.
LUNG CANCER (2001)
Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells
F Cheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
CM Alexander et al.
NATURE GENETICS (2000)
Semiquantitative reverse transcription-polymerase chain reaction analysis of syndecan-1 and-4 messages in cartilage and cultured chondrocytes from osteoarthritic joints
PE Barre et al.
OSTEOARTHRITIS AND CARTILAGE (2000)
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
J Schlessinger et al.
MOLECULAR CELL (2000)
Share Paper
